Jie et al. [58] suggested that metformin inhibition of the colon cancer cell and produced synergistic colon cancer-preventative effect in diabetic patients by modulating the expression of PKM2 and IDH1, two main isoenzymes involved in glycolysis and TCA cycles. Here, IDH1 is linked to malignant colon neoplasm.